Stay updated on SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial page.

Latest updates to the SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe Record History page now shows revision v3.6.4, replacing v3.6.3, indicating a software release for the site interface without altering study records.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page footer now displays Revision: v3.6.3, replacing Revision: v3.6.2, indicating a minor platform update.SummaryDifference0.0%

- Check39 days agoChange DetectedThe record history page now displays Revision: v3.6.2 instead of Revision: v3.6.0. This reflects a new version tag for the page's history content.SummaryDifference0.0%

- Check54 days agoChange DetectedThe record history shows the recruitment status changed from Active, not recruiting to Completed with a No longer looking for participants note; new status entries were added on 2026-06-04 and 2026-06-08, and the revision updated to v3.6.0.SummaryDifference0.6%

- Check61 days agoChange DetectedThe revision label on the page updated from v3.5.4 to v3.5.5, indicating a software update to the page. This change does not alter study data or user-facing functionality.SummaryDifference0.0%

- Check82 days agoChange DetectedFooter release tag updated to Revision: v3.5.4, reflecting a new platform version for the history page. The underlying study information remains unchanged.SummaryDifference0.0%

Stay in the know with updates to SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial page.